Mitochondrial targeting of the p13II protein coded by the x-II ORF of human T-cell leukemia/lymphotropic virus type I (HTLV-I)

[1]  W. Neupert,et al.  Protein import into mitochondria. , 1997, Annual review of biochemistry.

[2]  Ruedi Aebersold,et al.  Molecular characterization of mitochondrial apoptosis-inducing factor , 1999, Nature.

[3]  D. Green.  Apoptotic Pathways The Roads to Ruin , 1998, Cell.

[4]  M. Salas,et al.  Migration of Mitochondria to Viral Assembly Sites in African Swine Fever Virus-Infected Cells , 1998, Journal of Virology.

[5]  L. Ratner,et al.  Selective ablation of human T-cell lymphotropic virus type 1 p12I reduces viral infectivity in vivo. , 1998, Blood.

[6]  Lawrence M. Lifshitz,et al.  Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. , 1998, Science.

[7]  W. Fiers,et al.  The 55-kDa Tumor Necrosis Factor Receptor Induces Clustering of Mitochondria through Its Membrane-proximal Region* , 1998, The Journal of Biological Chemistry.

[8]  M. Osame,et al.  Antibody reactivities to tumor‐suppressor protein p53 and HTLV‐I Tof, Rex and Tax in HTLV‐I‐infected people with differing clinical status , 1997, International journal of cancer.

[9]  Dean P. Jones,et al.  Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked , 1997, Science.

[10]  D. Green,et al.  The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis , 1997, Science.

[11]  A. Rosato,et al.  The human T-cell lymphotropic virus type 1 Tof protein contains a bipartite nuclear localization signal that is able to functionally replace the amino-terminal domain of Rex , 1997, Journal of virology.

[12]  G. Kroemer,et al.  Bcl-2 inhibits the mitochondrial release of an apoptogenic protease , 1996, The Journal of experimental medicine.

[13]  Mitsuaki Yoshida.  Multiple targets of HTLV-1 for dysregulation of host cells , 1996 .

[14]  Xiaodong Wang,et al.  Induction of Apoptotic Program in Cell-Free Extracts: Requirement for dATP and Cytochrome c , 1996, Cell.

[15]  J. Ryerse,et al.  The E3-11.6-kDa adenovirus death protein (ADP) is required for efficient cell death: characterization of cells infected with adp mutants. , 1996, Virology.

[16]  W. Leonard,et al.  The human T-cell leukemia/lymphotropic virus type 1 p12I proteins bind the interleukin-2 receptor beta and gammac chains and affects their expression on the cell surface , 1996, Journal of virology.

[17]  G. Franchini.  Molecular mechanisms of human T-cell leukemia/lymphotropic virus type I infection. , 1995, Blood.

[18]  Tullio Pozzan,et al.  Chimeric green fluorescent protein as a tool for visualizing subcellular organelles in living cells , 1995, Current Biology.

[19]  F. Ruscetti,et al.  Virions released from cells transfected with a molecular clone of human T-cell leukemia virus type I give rise to primary and secondary infections of T cells , 1995, Journal of virology.

[20]  T. Hickish,et al.  Ultrastructural localization of BHRF1: an Epstein-Barr virus gene product which has homology with bcl-2. , 1994, Cancer research.

[21]  B. Rost,et al.  Combining evolutionary information and neural networks to predict protein secondary structure , 1994, Proteins.

[22]  R. Schlegel,et al.  The human T-cell leukemia/lymphotropic virus type I p12I protein cooperates with the E5 oncoprotein of bovine papillomavirus in cell transformation and binds the 16-kilodalton subunit of the vacuolar H+ ATPase , 1993, Journal of virology.

[23]  M. Rowe,et al.  Epstein-Barr virus-coded BHRF1 protein, a viral homologue of Bcl-2, protects human B cells from programmed cell death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  I. Koralnik,et al.  The p12I, p13II, and p30II proteins encoded by human T-cell leukemia/lymphotropic virus type I open reading frames I and II are localized in three different cellular compartments , 1993, Journal of virology.

[25]  Z. Berneman,et al.  Protein isoforms encoded by the pX region of human T-cell leukemia/lymphotropic virus type I. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[26]  M. Reitz,et al.  Expression of alternatively spliced human T-lymphotropic virus type I pX mRNA in infected cell lines and in primary uncultured cells from patients with adult T-cell leukemia/lymphoma and healthy carriers. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  G. Pavlakis,et al.  Complex splicing in the human T-cell leukemia virus (HTLV) family of retroviruses: novel mRNAs and proteins produced by HTLV type I , 1992, Journal of virology.

[28]  M. J. Cormier,et al.  Primary structure of the Aequorea victoria green-fluorescent protein. , 1992, Gene.

[29]  G. Pavlakis,et al.  Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting Rev-responsive element does not affect the fate of viral mRNA. , 1990, The New biologist.

[30]  E. Fenyö,et al.  Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1 , 1990, Journal of virology.

[31]  G. Pavlakis,et al.  Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. , 1990, Nucleic acids research.

[32]  A. van der Eb,et al.  A new technique for the assay of infectivity of human adenovirus 5 DNA. , 1973, Virology.

[33]  G. Azzone,et al.  Volume changes in liver mitochondria. , 1965, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Kroemer.  [Mitochondrial control of apoptosis]. , 2001, Bulletin de l'Academie nationale de medecine.

[35]  G. Miotto,et al.  Imaging the mitochondrial permeability transition pore in intact cells , 1998, BioFactors.

[36]  G. Kroemer,et al.  The mitochondrial death/life regulator in apoptosis and necrosis. , 1998, Annual review of physiology.

[37]  A. Rabson,et al.  Synthesis and Processing of Viral RNA , 1997 .